Literature DB >> 15768804

Role of reactive radicals in degeneration of the auditory system of mice following cisplatin treatment.

Ji Eun Lee1, Takayuki Nakagawa, Tae Soo Kim, Tsuyoshi Endo, Atsushi Shiga, Fukuichiro Iguchi, Sang Heun Lee, Juichi Ito.   

Abstract

OBJECTIVE: It has been suggested that reactive radical species are involved in the mechanism of cisplatin-induced hearing loss. However, the nature of the free radicals involved is not fully understood. We examined the effects of two highly reactive species, hydroxyl radicals and peroxynitrite, on the auditory system of mice following cisplatin treatment.
MATERIAL AND METHODS: Expression of 4-hydroxynonenal (HNE), a marker of lipid peroxidation by the hydroxyl radical, and nitrotyrosine (NT), a marker for protein peroxidation by peroxynitrite, was examined immunohistochemically in mouse cochleae injured by means of local application of cisplatin.
RESULTS: Loss of outer hair cells (OHCs) and spiral ganglia was found in cochleae affected by cisplatin. Both HNE and NT were detected in auditory epithelia and neurons damaged by cisplatin. Interestingly, auditory hair cells produced HNE, but not NT. Our findings indicate contributions by both HNE and NT to the degeneration of the auditory system due to cisplatin, and a crucial role of the hydroxyl radical in degeneration of OHCs.
CONCLUSION: The hydroxyl radical may be a critical target for a strategy aimed at protecting auditory function from cisplatin toxicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15768804     DOI: 10.1080/00016480410017521

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  21 in total

1.  Cisplatin ototoxicity affecting cochlear implant benefit.

Authors:  Michael S Harris; Jaimie L Gilbert; Kelly A Lormore; Swapna A Musunuru; Michael H Fritsch
Journal:  Otol Neurotol       Date:  2011-08       Impact factor: 2.311

2.  Cisplatin-induced ototoxicity is mediated by nitroxidative modification of cochlear proteins characterized by nitration of Lmo4.

Authors:  Samson Jamesdaniel; Donald Coling; Sneha Hinduja; Dalian Ding; Jun Li; Linda Cassidy; Gail M Seigel; Jun Qu; Richard Salvi
Journal:  J Biol Chem       Date:  2012-04-09       Impact factor: 5.157

Review 3.  Molecular mechanisms of resistance and toxicity associated with platinating agents.

Authors:  Cara A Rabik; M Eileen Dolan
Journal:  Cancer Treat Rev       Date:  2006-11-03       Impact factor: 12.111

4.  Protective effect of metformin against cisplatin-induced ototoxicity in an auditory cell line.

Authors:  Jiwon Chang; Hak Hyun Jung; Ji Yoon Yang; Sehee Lee; June Choi; Gi Jung Im; Sung Won Chae
Journal:  J Assoc Res Otolaryngol       Date:  2013-12-03

5.  Recovery of hearing in Cisplatin-induced ototoxicity in the Guinea pig with intratympanic dexamethasone.

Authors:  Caglar Calli; Ercan Pinar; Semih Oncel; H Alper Bagriyanik; E Umut Sakarya
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-02-09

Review 6.  Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.

Authors:  Jochen Schacht; Andra E Talaska; Leonard P Rybak
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

7.  Spiral ganglion cell loss is unrelated to segmental cochlear sensory system degeneration in humans.

Authors:  Fred H Linthicum; Jose N Fayad
Journal:  Otol Neurotol       Date:  2009-04       Impact factor: 2.311

Review 8.  Cisplatin ototoxicity and protection: clinical and experimental studies.

Authors:  Leonard P Rybak; Debashree Mukherjea; Sarvesh Jajoo; Vickram Ramkumar
Journal:  Tohoku J Exp Med       Date:  2009-11       Impact factor: 1.848

9.  Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity.

Authors:  Kelly Sheehan; Sandeep Sheth; Debashree Mukherjea; Leonard P Rybak; Vickram Ramkumar
Journal:  J Vis Exp       Date:  2018-03-16       Impact factor: 1.355

Review 10.  siRNA-mediated knock-down of NOX3: therapy for hearing loss?

Authors:  Leonard P Rybak; Debashree Mukherjea; Sarvesh Jajoo; Tejbeer Kaur; Vickram Ramkumar
Journal:  Cell Mol Life Sci       Date:  2012-05-05       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.